Genesis Healthcare, Inc.
GENN · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $3 | $3 | $4 | $4 |
| Enterprise Value | $3 | $3 | $3 | $4 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -5.1% | -9.7% | -2.2% | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 2.8% | 6.8% | -3.4% | 43% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 19.5% | 24.3% | 5.7% | 4.1% |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 7.4% | 8.8% | -3.6% | -0.8% |
| EPS Diluted | 0.33 | 0.42 | -0.28 | -0.15 |
| % Growth | -21.4% | 250% | -86.7% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | $0 |